|
|
|
|
| LEADER |
01202cam a2200349 a 4500 |
| 008 |
050506s2006 stka b 001 0 eng |
| 015 |
|
|
|a GBA571263
|2 bnb
|
| 016 |
7 |
|
|a 013279022
|2 Uk
|
| 016 |
7 |
|
|a 101264396
|2 DNLM
|
| 020 |
|
|
|a 0443064202
|
| 029 |
0 |
|
|a NLM
|b 101264396
|
| 035 |
|
|
|a (NNC)5585133
|
| 035 |
|
|
|a (OCoLC)ocm61440757
|
| 042 |
|
|
|a nlmcopyc
|
| 060 |
0 |
0 |
|a 2005 O-598
|
| 060 |
1 |
0 |
|a QV 744
|b D793345 2006
|
| 082 |
0 |
4 |
|a 615.19
|2 22
|
| 245 |
0 |
0 |
|a Drug discovery and development :
|b technology in transition /
|c edited by H.P. Rang ; foreword by Daniel Vasella.
|
| 260 |
|
|
|a Edinburgh ;
|a New York :
|b Churchill Livingstone / Elsevier,
|c 2006.
|
| 300 |
|
|
|a xii, 346 p. :
|b ill. ;
|c 27 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
1 |
2 |
|a Drug Design.
|
| 650 |
2 |
2 |
|a Biopharmaceutics.
|
| 650 |
2 |
2 |
|a Technology, Pharmaceutical.
|
| 700 |
1 |
|
|a Rang, H. P.
|
| 900 |
|
|
|a AUTH
|
| 942 |
|
|
|c BK
|
| 948 |
2 |
|
|a 20071011
|b a
|c rad1
|d MPS
|
| 948 |
2 |
|
|a 20071011
|b a
|c rad1
|d MPS
|
| 999 |
|
|
|c 151604
|d 151604
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_190000000000000_RAN_D
|7 0
|9 162035
|a BIO
|b BIO
|c ST1
|d 2018-08-23
|g 0.00
|i 1459
|l 0
|o 615.19 RAN/D
|p BIO1459
|r 2013-12-28
|w 2018-08-10
|y BK
|